"The cystic fibrosis (CF) drug Orkambi (Vertex Pharmaceuticals) has received a green light from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP).
Orkambi is a fixed-dose oral combination "...
Adverse reactions reported following use of VisionBlue® (trypan blue) include discoloration of high water content hydrogen intraocular lenses (see CONTRAINDICATIONS) and inadvertent staining of the posterior lens capsule and vitreous face. Staining of the posterior lens capsule or staining of the vitreous face is generally self limited, lasting up to one week.
Read the VisionBlue (trypan blue) Side Effects Center for a complete guide to possible side effects
No information provided.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 4/8/2009
Additional VisionBlue Information
Report Problems to the Food and Drug Administration
Find out what women really need.